NCT06706908

Brief Summary

INSPIRE is a prospective decentralized study evaluating post-operative health outcomes in patients who undergo a procedure using implants manufactured by SI-BONE.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
104mo left

Started Dec 2024

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress14%
Dec 2024Dec 2034

First Submitted

Initial submission to the registry

November 22, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

November 27, 2024

Completed
18 days until next milestone

Study Start

First participant enrolled

December 15, 2024

Completed
10 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2034

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2034

Last Updated

April 24, 2026

Status Verified

April 1, 2026

Enrollment Period

10 years

First QC Date

November 22, 2024

Last Update Submit

April 21, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in patient reported outcomes

    Change in pain as rated on a numerical rating scale (NRS), 0 being no pain and 10 being the worst pain imaginable at baseline and follow-up timepoints.

    From enrollment and at the following timepoints, 1-, 3-, 6-, and 12-months.

Secondary Outcomes (1)

  • Change in patient reported outcomes

    At the following timepoints: 1-, 3-, 6-, and 12-months.

Other Outcomes (1)

  • Postoperative incidence of:

    At the following timepoints, 1-, 3-, 6-, and 12-months.

Interventions

Participants are expected to complete a series of health questionnaires (i.e. numerical rating scale, Oswestry Disability Index) relevant to their treatment using a SI-BONE implant.

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients treated with an implant manufactured by SI-BONE.

You may qualify if:

  • Age \> 21 at time of screening.
  • Patient will undergo a procedure utilizing an iFuse Implant family product.
  • Patient is comfortable communicating in written and spoken English.
  • Patient is willing and able to complete study questionnaires online, using either a smartphone, tablet, or computer.
  • Patient is willing and able to provide informed consent to participate

You may not qualify if:

  • Patient has fibromyalgia.
  • Patient has a pain pump.
  • Patient is currently receiving or seeking worker's compensation, disability remuneration, and/or involved in injury litigation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

SI-BONE

Santa Clara, California, 94087, United States

Location

Study Officials

  • Robyn Capobianco, PhD

    SI-BONE

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 22, 2024

First Posted

November 27, 2024

Study Start

December 15, 2024

Primary Completion (Estimated)

December 1, 2034

Study Completion (Estimated)

December 1, 2034

Last Updated

April 24, 2026

Record last verified: 2026-04

Locations